Live feed
Filing
SC 13D
SC 13D0000904454-15-000250·KalVista Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Carbylan Therapeutics, Inc.
Security class unavailable · CUSIP: 141384107
Event date: 2015-04-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,204,562
- Percent of class
- 16.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-15-000250
- Form type
- SC 13D
- Filer
- KalVista Pharmaceuticals, Inc.
- CIK
- CIK 1348911
- Filed
- Apr 24, 2015
- Reporting period
- Apr 14, 2015
- Description
- Schedule 13D beneficial ownership